Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant
-
George Daskalakis
, Vasilios Pergialiotis
, Marianna Theodora
Abstract
Objectives
We designed an electronic query that was distributed to healthcare workers in order to evaluate their attitudes towards COVID-19 vaccination of women that wish to conceive and those that are pregnant.
Methods
An electronic survey was designed and distributed through a network of 5.654 e-mails. The query was uploaded in Google Forms.
Results
Overall, 1,226 answers were retrieved. Ninety percent of respondents replied that they prescribe COVID-19 vaccination in women that wish to conceive, however, the rate falls to 80% for those that have schedules for imminent artificial reproductive techniques. Approximately 1 in 2 physicians (obstetricians and pediatricians) suggests that a delay in assisted reproduction following immunization is not recommended. At least 13% of women of reproductive age and 30% of women wishing to conceive with ART declined to do so according to respondents, report. Only 75% of respondents favored immunization during pregnancy and of those 48% responded that vaccination could be done in all trimesters of pregnancy. Approximately 40% of women decline; however, to receive vaccination.
Conclusions
Despite the directions provided by international organizations; physician and patient hesitancy towards vaccination during pregnancy (and particularly the first trimester) remains an issue that deserves further attention.
The novel coronavirus disease (COVID‐19) outbreak has disrupted life globally reaching more than 200 million cases in August 2021 and nearly 4.5 million deaths [1, 2]. Epidemiologic studies suggest that the impact of the accompanying acute respiratory distress syndrome in pregnant women seems is accompanied by significant morbidity including risk of intubation, ICU admission, preterm birth and maternal mortality [3, 4]. Specifically, it seems that although pregnant women are less likely to present with symptoms such as fever, dyspnea, and myalgia, compared to the general population they have more than double the risk of being admitted to the NICU as well as 2.5 times the risk of requiring mechanical ventilation [5, 6]. Despite the fact that several organizations have issued specific guidelines that point towards vaccination of pregnant women [2, 7] there seem to be concerns among women and coverage seems to be quite low [8]. This attitude may be partially driven by the abundance of misinformation on the Internet that poses constraints to the uptake of the vaccine. To avoid the spread of misinformation the World Health Organization (WHO) has published an interim recommendation that specifically states that there is no need for pregnancy testing prior to vaccination, nor the need for delaying pregnancy because of vaccination [9].
On the other hand, maternal compliance with immunization protocols has been already documented [10]. However, it seems to be directly affected by physician compliance about their benefits in terms of reducing maternal and neonatal morbidity [10]. Previous studies addressing the issue of influenza vaccination in pregnant women have shown that the majority of patients perceives vaccination as riskier compared to the disease itself [11]. Positive physicians, attitude and appropriate guidance based on international recommendations can reverse this misperception. However, it seems that the various professions involved in healthcare seem to differ in terms of vaccine acceptability; therefore, implying a potential differential approach on the likelihood of vaccination of pregnant women as well as those that wish to conceive within the next few months [12].
To date, physicians’ and healthworkers’ perception about vaccination of pregnant women against COVID-19 is scarcely reported and it seems that a considerably minority of the sum of healthcare professionals seems to doubt about the benefits of vaccination during pregnancy [13]. This is driven by several reports that seem to argue the actual influence of the infection on maternal and neonatal pregnancy outcomes [14].
Taking this into consideration we conducted an anonymous electronic survey to evaluate this as well as to document their experience of womens’ attitudes to COVID-19 vaccination. The survey was distributed in May 2021 following notification about the benefits of vaccination in pregnant women. The study was approved by the institutional review board of Alexandra University Hospital of the National and Kapodistrian University of Athens. Healthcare workers agreed to participate in the present study.
Statistical analysis was performed in IBM SPSS (IBM Corp. Released 2015. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.). The normality of distribution was evaluated using the Kolmogorov Smirnov and graphical methods. Univariate and multivariate analyses were performed to evaluate the impact of health worker characteristics on the likelihood of suggesting the vaccination in pregnant women as well as women that wish to conceive naturally or with assisted reproduction.
Overall, 5.654 electronic mails were sent between May and July 2021 and 1,226 answers were retrieved (21.7% response rate). Of the sum of respondents, 504 were obstetricians, 214 midwifes and 176 pediatricians (Supplementary Material). Approximately 60% of them had either a Master of Science or a PhD, indicating a high level of education. The majority (58%) was involved in healthcare for more than 10 years. Approximately 80% of them prescribe the influenza and pertussis vaccine in pregnant women, indicating a high compliance with national standards on immunization of pregnant women. Ninety percent of respondents replied that they prescribe COVID-19 vaccination in women that wish to conceive, however, the rate falls to 80% for those that have schedules for imminent artificial reproductive techniques. Most respondents preferred to suggest vaccination with the mRNA vaccines (Supplementary Material).
Similar results were reported from obstetricians and pediatricians when analyzing the results that were retrieved from this subgroup of participants (90% responded that they would recommend COVID-19 immunization in women that wish to conceive).
At least 13% of women of reproductive age and 30% of women wishing to conceive with ART declined to do so according to respondents’ report. Approximately 38% of respondents suggested that the couple could try to conceive immediately, whereas the remaining answers referred to an interval that could preferably reach even six months from immunization. Approximately 1 in 2 physicians (obstetricians and pediatricians) suggests that a delay in ART is not recommended, whereas only 20% recommended an interval of 3–5 months.
Only 75% of respondents favored immunization during pregnancy and of those 48% responded that vaccination could be done in all trimesters of pregnancy. Approximately 40% of women decline; however, to receive vaccination. The mRNA vaccines were preferred from respondents. Of those that responded against vaccination of pregnant women the majority responded that they did so due to the increased risk of thrombosis and antenatal pathology. Five to 10% of them would suggest prenatal screening with one of the following methods: (i) non-invasive prenatal testing, (ii) chorionic villus sampling, (iii) amniocentesis or (iv) fetal cardiac ultrasound to ascertain normal pregnancy.
Following analysis (Tables 1 and 2) of the various factors that could potentially affect healthcare providers’ perception about vaccination of women that wish to conceive as well as of pregnant women, we observed that the most predominant factors of not suggesting vaccination were non-medical, non-midwife/nurse profession, non-involvement in higher education (MSc or PhD studies) as well as lack of adherence of guidelines for vaccination of pregnant women against seasonal flu and pertussis. Healthcare providers that were not vaccinated against COVID-19 were also less likely to suggest vaccination in both women that wish to conceive as well as pregnant women.
Bivariate analysis of factors affecting vaccination prior to pregnancy (Yes = reference).
Bivariate analysis variables | Crude OR (95% CI) | p-Value |
---|---|---|
Profession | ||
Ob/Gyn (ref) | – | – |
Pediatrician | 2.102 (1.123, 3.444) | 0.002 |
Ob/Gyn resident | 1.304 (0.048, 1.948) | 0.209 |
Pediatrics resident | 1.170 (0.314, 4.358) | 0.815 |
Midwife | 0.149 (0.009, 2.482) | 0.185 |
Nurse | 0.242 (0.068, 0.863) | 0.029 |
Other medical specialty | 0.961 (0.917, 1.006) | 0.091 |
Other healthcare provider | 3.424 (1.678, 6.417) | 0.027 |
Age | 0.961 (0.917, 1.006) | 0.091 |
Postdoc education | ||
None (ref) | – | – |
MSc | 1.674 (0.134, 1.233) | 0.112 |
PhD | 0.252 (0.86, 0.743) | 0.012 |
Years involved in obstetric/neonatal care | ||
>10 (ref) | – | – |
<5 years | 1.235 (0.879, 1.673) | 0.743 |
5–10 years | 1.037 (0.307, 3.508) | 0.953 |
2–5 years | 0.821 (0.236, 4.132) | 0.997 |
Births involved per year | ||
30–50 births (ref) | – | – |
>50 births | 1.638 (0.328, 8.100) | 0.550 |
<10 births | 1.335 (1.122, 1.917) | 0.033 |
10–30 births | 0.753 (0.301, 1.887) | 0.545 |
30–50 births | 1.996 (0.537, 7.423) | 0.302 |
Not involved | 2.638 (1.235, 4.012) | 0.006 |
Suggest influenza/pertussis vaccination | ||
Yes (ref) | – | – |
No | 4.782 (3.679, 5.982) | <0.001 |
Provider has done vaccination | ||
Yes (ref) | – | – |
12.824 (2.146, 22. 412) | 0.009 |
Bivariate analysis of factors affecting vaccination during pregnancy (Yes = reference).
Bivariate analysis variables | Crude OR (95% CI) | p-Value |
---|---|---|
Profession | ||
Ob/Gyn (ref) | – | – |
Pediatrician | 0.505 (0.274, 1.932) | 0.483 |
Ob/Gyn resident | 0.436 (0.033, 5.744) | 0.528 |
Pediatrics resident | 0.989 (0.575, 1.701) | 0.969 |
Midwife | 0.719 (0.235, 2.202) | 0.564 |
Nurse | 0.980 (0.956, 1.04) | 0.097 |
Other medical specialty | 1.386 (0.436, 4.403) | 0.580 |
Other healthcare provider | 3.201 (1.274, 6.634) | 0.029 |
Age | 0.699 (0.295, 1.654) | 0.415 |
Postdoc education | ||
None (ref) | – | – |
MSc | 0.471 (0.286, 0.777) | 0.003 |
PhD | 0.427 (0.263, 0.691) | 0.001 |
Years involved in obstetric/neonatal care | ||
>10 (ref) | – | – |
<5 years | 1.070 (0.504, 2.274) | 0.860 |
5–10 years | 2.254 (0.784, 6.481) | 0.132 |
2–5 years | Not estimable | >0.999 |
Births involved per year | ||
30–50 births (ref) | – | – |
>50 births | 1.317 (0.770, 2.251) | 0.314 |
<10 births | 1.129 (0.631, 2.017) | 0.683 |
10–30 births | 1.108 (0.605, 2.032) | 0.740 |
30–50 births | 0.654 (0.321, 1.330) | 0.241 |
Not involved | 1.653 (1.180, 2.132) | 0.021 |
Suggest influenza/pertussis vaccination | ||
Yes (ref) | – | – |
No | 3.131 (1.654, 5.428) | 0.002 |
Provider has done vaccination | ||
Yes (ref) | – | – |
8.324 (1.182, 21.203) | 0.047 |
The findings of our study suggest that acceptance of vaccination of women that wish to conceive is high among healthworkers and even higher among obstetricians and pediatricians. However, there seems to be a moderate reluctance towards suggesting immunization of pregnant women and especially when it comes to vaccination during the first trimester of pregnancy. Several factors seem to influence the decision to recommend vaccination, including the level of education as well as the lack of adherence to current recommendations for vaccination of pregnant women against seasonal flu and pertussis. Taking this into consideration, we believe that further actions are needed to increase compliance of both groups, as evidence-informed recommendations will strengthen both the demand and delivery of vaccines.
-
Research funding: None declared.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The local Institutional Review Board approved the present study.
-
Disclosure: The authors report no conflict of interest.
References
1. Worldometer COVID-19 Coronavirus pandemic. Available from: https://www.worldometers.info/coronavirus/ [Accessed 15 Aug 2021].Suche in Google Scholar
2. American College of Obstetricians and Gynecologists Practice Advisory Novel Coronavirus 2019 (COVID-19). Available from: https://wwwacogorg/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019.Suche in Google Scholar
3. Chinn, J, Sedighim, S, Kirby, KA, Hohmann, S, Hameed, AB, Jolley, J, et al.. Characteristics and outcomes of women with COVID-19 giving birth at US Academic Centers during the COVID-19 pandemic. JAMA Netw Open 2021;4:e2120456. https://doi.org/10.1001/jamanetworkopen.2021.20456.Suche in Google Scholar PubMed PubMed Central
4. Ciapponi, A, Bardach, A, Comandé, D, Berrueta, M, Argento, FJ, Rodriguez Cairoli, F, et al.. COVID-19 and pregnancy: an umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes. PLoS One 2021;16:e0253974. https://doi.org/10.1371/journal.pone.0253974.Suche in Google Scholar PubMed PubMed Central
5. Khan, DSA, Pirzada, AN, Ali, A, Salam, RA, Das, JK, Lassi, ZS. The differences in clinical presentation, management, and prognosis of laboratory-confirmed COVID-19 between pregnant and non-pregnant women: a systematic review and meta-analysis. 2021;18. https://doi.org/10.3390/ijerph18115613.Suche in Google Scholar PubMed PubMed Central
6. Allotey, J, Stallings, E, Bonet, M, Yap, M, Chatterjee, S, Kew, T, et al.. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320. https://doi.org/10.1136/bmj.m3320.Suche in Google Scholar PubMed PubMed Central
7. Centers for Disease Control and Prevention. COVID-19 vaccines while pregnant or Breastfeeding. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html [Accessed 11 Aug 2021].Suche in Google Scholar
8. Blakeway, H, Prasad, S, Kalafat, E, Heath, PT, Ladhani, SN, Le Doare, K, et al.. COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol 2021. https://doi.org/10.1016/j.ajog.2021.08.007.Suche in Google Scholar PubMed PubMed Central
9. World Health Organization. Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under emergency use listing. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1 [Accessed 14 Nov 2021].Suche in Google Scholar
10. Healy, CM, Rench, MA, Montesinos, DP, Ng, N, Swaim, LS. Knowledge and attitiudes of pregnant women and their providers towards recommendations for immunization during pregnancy. Vaccine 2015;33:5445–51. https://doi.org/10.1016/j.vaccine.2015.08.028.Suche in Google Scholar PubMed
11. Bödeker, B, Betsch, C, Wichmann, O. Skewed risk perceptions in pregnant women: the case of influenza vaccination. BMC Publ Health 2015;15:1308.10.1186/s12889-015-2621-5Suche in Google Scholar PubMed PubMed Central
12. Iguacel, I, Luna Maldonado, A, Luna Ruiz-Cabello, A, Samatán, E, Alarcón, J, Ángeles Orte, M, et al.. Attitudes of healthcare professionals and general population toward vaccines and the intention to Be vaccinated against COVID-19 in Spain. Front Publ Health 2021;9. https://doi.org/10.3389/fpubh.2021.739003.Suche in Google Scholar PubMed PubMed Central
13. Deruelle, P, Couffignal, C, Sibiude, J, Vivanti, AJ, Anselem, O, Luton, D, et al.. Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women. PLoS One 2021;16:e0256080. https://doi.org/10.1371/journal.pone.0256080.Suche in Google Scholar PubMed PubMed Central
14. Di Toro, F, Gjoka, M, Di Lorenzo, G, De Santo, D, De Seta, F, Maso, G, et al.. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect 2021;27:36–46. https://doi.org/10.1016/j.cmi.2020.10.007.Suche in Google Scholar PubMed PubMed Central
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/jpm-2021-0536).
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Corner of Academy
- Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies
- Adverse perinatal outcomes following the prenatal diagnosis of isolated single umbilical artery in singleton pregnancies: a systematic review and meta-analysis
- Original Articles – Obstetrics
- Perinatal outcomes in women with severe acute respiratory syndrome coronavirus 2 infection: comparison with contemporary and matched pre-COVID-19 controls
- The postpartum period during the COVID-19 pandemic: investigating Turkish women’s postpartum support and postpartum-specific anxiety
- First-line noninvasive management of cytomegalovirus primary infection in pregnancy
- Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
- Improved management of placenta accreta spectrum disorders: experience from a single institution
- A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- The impact of preimplantation genetic testing for aneuploidy on prenatal screening
- Original Articles – Fetus
- Myocardial deformation analysis in late-onset small-for-gestational-age and growth-restricted fetuses using two-dimensional speckle tracking echocardiography: a prospective cohort study
- HDlive Flow Silhouette with spatiotemporal image correlation for assessment of fetal cardiac structures at 12 to 14 + 6 weeks of gestation
- Umbilical artery pulsatility index and half-peak systolic velocity in second- and third-trimester fetuses with trisomy 18 and 13
- Original Articles – Neonates
- Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation
- Outcomes from birth to 6 months of publicly insured infants born to mothers with severe acute respiratory syndrome coronavirus 2 infection in the United States
- Placental findings are not associated with neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy – an 11-year single-center experience
- High frequency band limits in spectral analysis of heart rate variability in preterm infants
- Bacterial DNA detection in very preterm infants assessed for risk of early onset sepsis
- Short Communication
- Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant
- Letter to the Editors
- Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- Re: Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- SARS-CoV-2 behavior, through the eyes of a perinatologist?
- Re: SARS-CoV-2 behavior, through the eyes of a perinatologist?
Artikel in diesem Heft
- Frontmatter
- Corner of Academy
- Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies
- Adverse perinatal outcomes following the prenatal diagnosis of isolated single umbilical artery in singleton pregnancies: a systematic review and meta-analysis
- Original Articles – Obstetrics
- Perinatal outcomes in women with severe acute respiratory syndrome coronavirus 2 infection: comparison with contemporary and matched pre-COVID-19 controls
- The postpartum period during the COVID-19 pandemic: investigating Turkish women’s postpartum support and postpartum-specific anxiety
- First-line noninvasive management of cytomegalovirus primary infection in pregnancy
- Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders
- Improved management of placenta accreta spectrum disorders: experience from a single institution
- A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- The impact of preimplantation genetic testing for aneuploidy on prenatal screening
- Original Articles – Fetus
- Myocardial deformation analysis in late-onset small-for-gestational-age and growth-restricted fetuses using two-dimensional speckle tracking echocardiography: a prospective cohort study
- HDlive Flow Silhouette with spatiotemporal image correlation for assessment of fetal cardiac structures at 12 to 14 + 6 weeks of gestation
- Umbilical artery pulsatility index and half-peak systolic velocity in second- and third-trimester fetuses with trisomy 18 and 13
- Original Articles – Neonates
- Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation
- Outcomes from birth to 6 months of publicly insured infants born to mothers with severe acute respiratory syndrome coronavirus 2 infection in the United States
- Placental findings are not associated with neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy – an 11-year single-center experience
- High frequency band limits in spectral analysis of heart rate variability in preterm infants
- Bacterial DNA detection in very preterm infants assessed for risk of early onset sepsis
- Short Communication
- Healthcare workers’ attitudes about vaccination of pregnant women and those wishing to become pregnant
- Letter to the Editors
- Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- Re: Comment on Abdel Wahab et al.: A randomized controlled trial of two-doses of vaginal progesterone 400 vs. 200 mg for prevention of preterm labor in twin gestations
- SARS-CoV-2 behavior, through the eyes of a perinatologist?
- Re: SARS-CoV-2 behavior, through the eyes of a perinatologist?